Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation
Open Access
- 1 March 2018
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 143 (4) , 746-757
Abstract
Limited epidemiological evidence suggests that the etiology of hormone receptor positive (HR+) breast cancer may differ by levels of histologic grade and proliferation. We pooled risk factor and pathology data on 5,905 HR+ breast cancer cases and 26,281 controls from 11 epidemiological studies. Proliferation was determined by centralized automated measures of KI67 in tissue microarrays. Odds ratios (OR), 95% confidence intervals (CI) and p‐values for case–case and case–control comparisons for risk factors in relation to levels of grade and quartiles (Q1–Q4) of KI67 were estimated using polytomous logistic regression models. Case–case comparisons showed associations between nulliparity and high KI67 [OR (95% CI) for Q4 vs. Q1 = 1.54 (1.22, 1.95)]; obesity and high grade [grade 3 vs. 1 = 1.68 (1.31, 2.16)] and current use of combined hormone therapy (HT) and low grade [grade 3 vs. 1 = 0.27 (0.16, 0.44)] tumors. In case–control comparisons, nulliparity was associated with elevated risk of tumors with high but not low levels of proliferation [1.43 (1.14, 1.81) for KI67 Q4 vs. 0.83 (0.60, 1.14) for KI67 Q1]; obesity among women ≥50 years with high but not low grade tumors [1.55 (1.17, 2.06) for grade 3 vs. 0.88 (0.66, 1.16) for grade 1] and HT with low but not high grade tumors [3.07 (2.22, 4.23) for grade 1 vs. 0.85 (0.55, 1.30) for grade 3]. Menarcheal age and family history were similarly associated with HR+ tumors of different grade or KI67 levels. These findings provide insights into the etiologic heterogeneity of HR+ tumors.Keywords
Funding Information
- Deutsche Krebshilfe (70‐2892‐BR I, 106332, 108253, 108419)
- Deutsches Krebsforschungszentrum
- Dutch Cancer Society (UL1997‐1505)
- Dutch Cancer Society (DDHK 2004‐3124, DDHK 2009‐4318)
- Cancer Research UK (C490/A10124, C490/A16561)
This publication has 51 references indexed in Scilit:
- Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancerBritish Journal of Cancer, 2012
- Traditional breast cancer risk factors in relation to molecular subtypes of breast cancerBreast Cancer Research and Treatment, 2011
- Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium StudiesJNCI: Journal of the National Cancer Institute, 2010
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of SwitzerlandAnnals of Oncology, 2008
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Established breast cancer risk factors by clinically important tumour characteristicsBritish Journal of Cancer, 2006
- Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC)International Journal of Cancer, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001